Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,831 INR | -1.05% | +2.78% | -6.96% |
16/04 | Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak | CI |
28/03 | Alkem Laboratories Forms Subsidiary for Medical Devices Business | MT |
Sales 2024 * | 129B 1.55B | Sales 2025 * | 142B 1.7B | Capitalization | 584B 7B |
---|---|---|---|---|---|
Net income 2024 * | 18.67B 224M | Net income 2025 * | 21.7B 260M | EV / Sales 2024 * | 4.37 x |
Net cash position 2024 * | 20.12B 241M | Net cash position 2025 * | 27.86B 334M | EV / Sales 2025 * | 3.91 x |
P/E ratio 2024 * |
31.9
x | P/E ratio 2025 * |
27.1
x | Employees | 16,871 |
Yield 2024 * |
0.89% | Yield 2025 * |
1% | Free-Float | 36.2% |
Latest transcript on Alkem Laboratories Limited
1 day | -1.05% | ||
1 week | +2.78% | ||
Current month | -2.20% | ||
1 month | -3.46% | ||
3 months | -2.38% | ||
6 months | +30.91% | ||
Current year | -6.96% |
Managers | Title | Age | Since |
---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 22/23/22 |
Nitin Agrawal
DFI | Director of Finance/CFO | - | 01/02 |
Manish Narang
CMP | Compliance Officer | 54 | 01/06/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Chief Executive Officer | 84 | 08/73/08 | |
Sudha Ravi
BRD | Director/Board Member | 68 | 29/15/29 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 4,831 | -1.05% | 1 196 |
29/24/29 | 4,883 | -0.38% | 3,778 |
26/24/26 | 4,902 | +0.62% | 139,669 |
25/24/25 | 4,871 | +3.39% | 1,969 |
24/24/24 | 4,712 | +0.24% | 677 |
Delayed Quote Bombay S.E., April 30, 2024 at 03:30 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.47% | 664B | |
+30.44% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+14.30% | 234B | |
+5.00% | 199B | |
-10.10% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- ALKEM Stock
- ALKEM Stock